Evidence map›Paper›PMID 36439263›Full record

SynthesisFrontiers in physiology2022

Cys-loop receptors on cannabinoids: All high?

Philip Schmiedhofer, Florian Daniel Vogel, Filip Koniuszewski, Margot Ernst

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Frontiers in physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. The Pharmacological Profile of Plant-Derived Cannabinoids In Vitro.Current topics in behavioral neurosciences · 2026
    Review
  3. Review
  4. The Polypharmacological Effects of Cannabidiol.Molecules (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Philip SchmiedhoferSBR Development Holding, Vienna, Austria.
Florian Daniel VogelDepartment of Pathobiology of the Nervous System, Center for Brain Research, Medical University Vienna, Vienna, Austria.
Filip KoniuszewskiDepartment of Pathobiology of the Nervous System, Center for Brain Research, Medical University Vienna, Vienna, Austria.
Margot ErnstDepartment of Pathobiology of the Nervous System, Center for Brain Research, Medical University Vienna, Vienna, Austria.
Medical University of Vienna · ATSBA Research · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endocannabinoids (eCBS) are endogenously derived lipid signaling molecules that serve as tissue hormones and interact with multiple targets, mostly within the endocannabinoid system (ECS). The ECS is a highly conserved regulatory system involved in homeostatic regulation, organ formation, and immunomodulation of chordates. The term "cannabinoid" evolved from the distinctive class of plant compounds found in

Indexed as

cannabinoidcbdchronic painCys-loop receptorsepilepsypolypharmacologypolypharmacythc

Identifiers

PMID36439263
PMCPMC9682269
OpenAlexW4308719637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.